Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
14.13
+0.36 (2.61%)
At close: Jun 24, 2025, 4:00 PM
14.14
+0.01 (0.07%)
After-hours: Jun 24, 2025, 4:40 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $921.58 million as of June 24, 2025. Its market cap has increased by 38.01% in one year.
Market Cap
921.58M
Enterprise Value
578.55M
1-Year Change
38.01%
Ranking
Category
Stock Price
$14.13
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $921.58M, an increase of 47.47%. That is a compound annual growth rate of 17.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 921.58M | 50.42% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 362.07B |
| Novo Nordisk | 326.28B |
| AbbVie | 323.32B |
| UnitedHealth Group | 272.84B |
| Abbott Laboratories | 231.17B |
| Novartis AG | 229.25B |
| AstraZeneca | 217.06B |